Persista Bio Inc.
PrivateLast Round
Pre Seed
Feb 5, 2026
Total Funding Raised
$2.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Persista Bio Inc. is a biotechnology company that develops an oxygenated cell therapy platform designed to enable long-term, immunosuppression-free cell implants for the treatment of Type 1 diabetes and other chronic conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Persista Bio Inc. Comparables
Compare Persista Bio Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Encellin | 86% | |
| Procyon Technologies LLC | 86% | |
| iTolerance, Inc. | 80% | |
Persista Bio Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Feb 5, 2026 | ||||
| Accelerator | Oct 1, 2025 | ||||
| Grant | Sep 23, 2025 | ||||
| Seed | Sep 23, 2025 |
Key People
Founding team and executive leadership
Persista Bio Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| Kevin M. McGovern Family Center for Venture Development in the Life Sciences | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Grew 38% QoQ from 8 to 11 employees.
- Apr 17, 2026
Monthly visitors grew 234% MoM, reaching 277.
Persista Bio Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Persista Bio Inc.'s valuation, stock price, and market status.